Skip to content
For laboratory research use only · Not for human consumption
Pioneer Labs

Hormone analogs / Research guide

SMA.

A little deeper. A clearer picture.

One modified peptide with one receptor target. SMA, originally NN9535, was designed through targeted peptide modifications intended to alter enzymatic stability and albumin association.

For research use onlyView SMA sizes
Published by Pioneer LabsUpdated Sources & editorial standards

01 / Molecular architecture

A closer look at the chain.

The 31-residue design includes an Aib substitution at an enzyme-sensitive position and an attached fatty-diacid side chain. These modifications matter alongside the peptide backbone when identifying the reference molecule.

Pioneer / Reference notesMolecular features
  • 31 residues
  • Aib substitution
  • Lipid side chain
Structural features shown schematically, not a full sequence or three-dimensional model.

Reference information: [1][2]. Actual lot identity must be verified separately.

A peptide with an attached side chain.

SMA’s design includes backbone modifications and a fatty-diacid side chain connected through a linker. The attachment is part of a single modified molecule, not a second peptide in a blend. The reference therefore needs more than a plain amino-acid list to describe its complete architecture.

Molecular design and assay context.

The discovery work examined chemical modifications alongside albumin interaction and activity at SMA’s receptor target. These are different experimental properties. A protein-binding measurement does not directly state receptor activity, and neither is interchangeable with a chemical identity test of a sample.

Structure and research references: [1]

02 / Read the evidence

Research & analytical context.

The discovery paper includes structure–activity comparisons and receptor testing of candidate analogs. The molecular design combines changes to the peptide backbone with a lipid side chain. Both need to be described when identifying the reference structure.

Read the references: [1][2].

The distinction that matters

SMA is structurally distinct from other analogs with the same receptor target. A shared target does not establish matching sequences, side chains or analytical specifications.

03 / From reference to record

Know the lot, too.

A publication describes its own test material. Your lot’s certificate describes what was tested on that lot. Keep the compound name, batch number and reported methods together when reviewing a result.

Identity & composition

Check sequence or chemical form, terminal modifications, counterion and—where relevant—each blend component.

Analytical results

Read purity, content, sterility and endotoxin results as separate measurements. Only call a test passed when the actual report supports it.

Handling & storage notes

Lyophilized material: Store at −20°C; protect from light and moisture.

Follow the material-specific label and supporting storage documentation. These temperatures do not establish a shelf life.

How to store lyophilized peptides

04 / Reference questions

A few details, explained.

Does lipidation mean two compounds were mixed?

Here it describes a covalently attached chemical feature on the reference peptide. A mixture of unattached ingredients would have a different molecular description.

Is SMA the same dual-target design as TRZ?

No. SMA’s reference profile has one receptor target where TRZ’s has two, and their molecular designs differ. A shared receptor target does not make the structures equivalent.

Read alongside the references: [1]

05 / Continue reading

Go to the source.